ASHG 2026 has ended. This guide stays up as the record of who was there. Next: ASHG 2027, Oct 26–30, 2027 in Nashville

University of Edinburgh at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

University of Edinburgh brings 5 presentations from 3 research groups to ASHG 2026 in Montréal. Its program centres on rare disease, cancer, and computational and clinical genetics, with therapeutic applications. Genetic Targets and Precision Medicine studies B-cell activation in primary biliary cholangitis, Biomedical Informatics Group builds a multimodal rare-disease knowledge graph, and Usher Institute examines founder effects in the Scottish Isles.

OrganizationASHG 2026 Attendance
2 Postdocs · 2 PhD Students
Genetic Targets and Precision Medicineprecmed.cphs.mvm.ed.ac.uk
Dry lab~6 people
Uses deidentified electronic health records, genetic and biomarker data, and GENOSCORES. Prioritizes drug targets and informs diagnosis, prognosis, treatment and drug-safety decisions.
Funded by European Foundation for the Study of Diabetes, Diabetes UK +5 more
›
Diabetes UK, Real-world pharmacoepidemiology of drugs used in diabetes · 2/1/25 → 1/1/2028
“Real-world pharmacoepidemiology of drugs used in diabetes: harnessing e-health records and artificial intelligence. Colhoun H, McKeigue P. Diabetes UK 2/1/25 → 1/1/2028.”
European Foundation for the Study of Diabetes, Identifying drug targets for type 1 diabetes by genome-wide aggregated trans-effects analysis · 1/3/26 → 28/2/27
“Identifying drug targets for type 1 diabetes by genome-wide aggregated trans-effects analysis. European Foundation for the Study of Diabetes 1/3/26 → 28/2/27.”
Iqvia Ltd, EXCEED · 01/07/21 → 01/05/27
“EXCEED - A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients who Initiated Exenatide as Compared with those who Initiated Other non-Glucagon-Like Peptide 1 Receptor Agonists Colhoun H, McKeigue P. Iqvia Ltd 01/07/21 → 01/05/27.”
+4 more on the lab page
Source: lab pages
11 platforms and techniques
›
Analyzes
GENOSCORES, Deidentified electronic-health-record analysis platform, SomaScan, Olink
Techniques
Statistical genetics, Bayesian methods, Machine learning, Genome-wide aggregated trans-effects analysis, Trans-eQTL analysis, Trans-pQTL analysis, Causal inference
Source: lab pages
No openings posted
Talk
Wed Oct 21
2:03 pm
Genome-wide aggregated trans-effects analysis reveals B-cell activation and checkpoint signalling as therapeutic axes in primary biliary cholangitis
Collaborators: Toronto General Hospital, Lunenfeld-Tanenbaum Research Institute
Genome-wide association studyAutoimmune disorderProteomicsGene regulation
Poster
Wed Oct 21
2:30 pm
★ Reviewers’ Choice
Genome-wide aggregated trans-effects analysis reveals B-cell activation and checkpoint signalling as therapeutic axes in primary biliary cholangitis
Collaborators: Toronto General Hospital, Lunenfeld-Tanenbaum Research Institute
Autoimmune disorderGene regulationGenome-wide association studyIdentification of disease genes
Poster
Wed Oct 21
2:30 pm
From core-gene discovery to mechanism: biological function, accumulating evidence of causality, and rare-variant convergence in essential hypertension
Collaborators: Institute of Genetics and Cancer
Cardiovascular systemIdentification of disease genesProteomicsExpression quantitative trait loci
Biomedical Informatics Groupbiomedicalinformaticsgroup.github.io/people
Dry lab~15 people
Develops statistical and machine-learning methods for whole-genome, RNA-seq and clinical data. Targets rare genetic disease diagnosis, autism and Parkinson’s stratification, and cancer biomarker discovery.
7 papers since 2024
›
Drug-Induced Liver Injury Associated with Turmeric and Piperine: A Case and Review
Case Reports in Gastroenterology, 2025
Embracing Scientific Debate in Brain Metabolism
Journal of Neurochemistry, 2025
Triterpenoid wax esters confirm Ficus religiosa in archaeological sequences within the Mayadevi temple shrine, Lumbini – the birthplace of Buddha
Frontiers in Geochemistry, 2025
Source: OpenAlex author A5069540793
Funded by Wellcome Trust, Simons Foundation for Autism Research Initiative (SFARI) +1 more
›
UKRI, AI Centre for Doctoral Training in Biomedical Innovation · 2024-2032
“Director UKRI AI Centre for Doctoral Training in Biomedical Innovation (2024-2032)”
Simons Foundation for Autism Research Initiative (SFARI), translational project · Since 2018
“Since 2018 I have been involved in a translational project funded by the Simons Foundation for Autism Research Initiative (SFARI)”
Wellcome Trust · active
“We are using our biomedical natural language processing and network methods in a £5.5m Wellcome Trust funded collaboration”
Source: lab pages
14 platforms and techniques
›
Analyzes
whole-genome sequencing, RNA microarrays, RNA-seq, single-cell RNA-seq, next-generation sequencing (NGS), high-throughput DNA sequencing
Techniques
network fusion, graph neural networks, biomedical natural language processing, topic modelling, BioBERT, knowledge graphs, Kappa Language rule-based modeling, ordinary differential equation modeling
Source: lab pages
No openings posted
Poster
Fri Oct 23
2:30 pm
A knowledge graph framework for multimodal genotype-phenotype integration in rare genetic diseases
Genotype-phenotype correlationsRare variantsMachine learningCharacterization of disorders
Usher Instituteed.ac.uk/usher
Dry lab~284 people
Analyzes Generation Scotland genetic and e-HR data and EAVE II linked GP, vaccination and hospital data. Works with Public Health Scotland on population health.
Funded by Medical Research Council, National Institute for Health Research +4 more
›
Health Data Research UK, Inflammation and Immunity Driver Programme · 2023-28
“Inflammation and Immunity core funding was awarded by Health Data Research UK (HDR UK).”
Medical Research Council, EAVE II · active
“EAVE II is funded by the Medical Research Council [MR/R008345/1]”
National Institute for Health Research, EAVE II · active
“EAVE II is funded by the Medical Research Council, National Institute for Health Research, Health Data Research UK and the HDR UK BREATHE Hub”
+3 more on the lab page
Source: lab pages
15 platforms and techniques
›
Analyzes
Generation Scotland, EAVE II, DataLoch Secure Data Environment, Viral sequencing, OMOP Common Data Model, DNA and exome sequencing, MRI and CT scans
Techniques
Genotyping, Machine learning and deep learning, Natural language processing, Statistical modeling, Mendelian randomization, Data linkage, Phylogenetics, Polygenic risk scores
Source: lab pages
Currently hiring
›
“Join our growing team of academics and professional services staff”
Source: lab positions page
Poster
Thu Oct 22
4:15 pm

Explore the full ASHG 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Download the full ASHG 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of Edinburgh

Tell us what you sell and we’ll find the people at University of Edinburgh most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction